Get the Stockscreener App
44.32
0.74%
-0.33
Qiagen Nv stock is traded at $44.32, with a volume of 1.28M.
It is down -0.74% in the last 24 hours and down -6.69% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$44.65
Open:
$44.49
24h Volume:
1.28M
Relative Volume:
1.09
Market Cap:
$9.68B
Revenue:
$2.04B
Net Income/Loss:
$373.39M
P/E Ratio:
26.13
EPS:
1.6961
Net Cash Flow:
$495.96M
1W Performance:
+1.74%
1M Performance:
-6.69%
6M Performance:
+7.70%
1Y Performance:
+2.37%
1-Day Range:
$44.23
$45.36
1-Week Range:
$43.02
$45.36
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.32 | 9.68B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
Is Qiagen N.V. (QIA) stock a defensive play amid uncertaintyJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Can Qiagen N.V. (QIA) stock resist broad market declinesMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
What momentum shifts mean for Qiagen N.V.2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Using portfolio simulators with Qiagen N.V. includedGold Moves & Reliable Entry Point Alerts - newser.com
Is Qiagen N.V. Common Shares stock testing key support2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will Qiagen N.V. see short term momentumJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Is Qiagen N.V. (QIA) stock a top hedge fund pickJuly 2025 Patterns & Weekly High Momentum Picks - newser.com
Is Qiagen N.V. stock attractive for passive investorsCEO Change & Consistent Growth Equity Picks - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
164,900 Shares in Qiagen N.V. $QGEN Purchased by Jupiter Asset Management Ltd. - MarketBeat
What data driven models say about Qiagen N.V.’s futureExit Point & Weekly Momentum Picks - newser.com
How Qiagen N.V. Common Shares stock performs in easing cyclesJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Is Qiagen N.V. stock cheap at current valuationTake Profit & Precise Swing Trade Entry Alerts - newser.com
Is Qiagen N.V. stock a safe haven asset2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Wellington Management Group LLP Reduces Stake in Qiagen NV - GuruFocus
Is Qiagen N.V. Common Shares stock a buy for dividend portfoliosTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will Qiagen N.V. (QIA) stock keep high P E multiplesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Can Qiagen N.V. stock hit record highs againJuly 2025 Chart Watch & Smart Investment Allocation Tips - Fundação Cultural do Pará
Bank of New York Mellon Corp Has $39.79 Million Holdings in Qiagen N.V. $QGEN - MarketBeat
Is Qiagen N.V. stock cheap compared to fundamentalsJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Full technical analysis of Qiagen N.V. stockEarnings Miss & Weekly Breakout Stock Alerts - newser.com
What downside risks could hit Qiagen N.V. Common Shares stockJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Volume spikes in Qiagen N.V. stock – what they meanQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Pryor Cashman Represents Soleus Capital In Sale Of Parse Biosciences To QIAGEN N.V. For Up To $280 Million - MarketScreener
We Think Qiagen's (NYSE:QGEN) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):